"We are extremely pleased that the FDA granted Fast Track Designation to CUSP06," said Eric Slosberg, PhD, Chief Development Officer of OnCusp Therapeutics. "The early results from our Phase 1 trial ...

MaxCyte ( NASDAQ: MXCT) Wednesday said that it had entered into a strategic platform license with TG Therapeutics, a fully integrated, commercial-stage, biopharmaceutical company focused on the ...

Over the past few years, the software development market in the UK has witnessed incredible growth, making it a popular hub for technological advancements. The country has attracted multiple startups ...

Automated fuel transaction tracking boosts cost efficiency and curbs loss, fraud BIRMINGHAM, AL, Feb. 12, 2025 (GLOBE ...

Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

A cardiac surgery and heart failure team at the University of Michigan implanted a novel mechanical heart pump into a patient as part of a clinical trial that will compare it to the only device ...

Reprieve Cardiovascular, Inc., a development-stage company focused on advancing acute decompensated heart failure (ADHF) ...

Burger has been a key man for Stoke since his August 2023 arrival, despite dips in form over the last 12 months, but was reported to be closing in on a move to the four-time Danish champions on the ...